Literature DB >> 25291160

Impact of hepatic cirrhosis on outcome in adult cardiac surgery.

Ioannis Dimarakis1, Stuart Grant1, Rebecca Corless2, Theodore Velissaris3, Martin Prince4, Ben Bridgewater1, George Asimakopoulos5.   

Abstract

Increasing prevalence of hepatic disease is likely to translate in a growing number of patients with significant hepatic disease requiring cardiac surgery. Available cardiac risk stratification models do not address the risk associated with hepatic disease. However, weighted mean mortality rates based on previous studies of cardiac surgery in patients with hepatic disease demonstrate operative mortality rates that range from 9.88% (standard deviation [SD] 9.69) for patients in Child-Turcotte-Pugh (CTP) class A cirrhosis to 69.23% (SD 28.55) for patients with CTP class C cirrhosis. This review comprehensively appraises the pathophysiology of hepatic disease, reported clinical outcomes and considerations for risk stratification. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2014        PMID: 25291160     DOI: 10.1055/s-0034-1389084

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  3 in total

1.  Helpfulness of the liver disease scores in cardiac surgery for cirrhotic patients.

Authors:  Alexandre Sebestyen; Alaae Boutayeb; Michel Durand; Cécile Martin; Marie-Noëlle Hilleret; Damien Bedague; Delphine Rhem; Olivier Chavanon
Journal:  Gen Thorac Cardiovasc Surg       Date:  2022-03-20

2.  Outcomes and risk factors of postoperative hepatic dysfunction in patients undergoing acute type A aortic dissection surgery.

Authors:  Wei Zhou; Guokun Wang; Yaoyang Liu; Yun Tao; Zhen Du; Yangfeng Tang; Fan Qiao; Yang Liu; Zhiyun Xu
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

3.  Does age over 80 years have to be a contraindication for lung cancer surgery-a nationwide database study.

Authors:  Pierre-Benoit Pagès; Anne-Sophie Mariet; Arnaud Pforr; Jonathan Cottenet; Leslie Madelaine; Halim Abou-Hanna; Alain Bernard; Catherine Quantin
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.